Evidence map›Paper›PMID 40863504›Full record

ArticleJournal of fungi (Basel, Switzerland)2025

Ezgi Gülten, Güle Çınar, Elif Mukime Sarıcaoğlu, İrem Akdemir, Afife Zeynep Yılmaz, Elif Hilal Saldere, Fügen Yörük

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Changes in Epidemiology of Candidemia in the United States With a Focus on Candida auris.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Clinical and Microbiological Characteristics of EarlyAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Clinical Outcomes ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Mortality ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ezgi GültenDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0003-0248-7716
Güle ÇınarDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0002-7635-8848
Elif Mukime SarıcaoğluDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0002-7613-2398
İrem AkdemirDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0001-5136-9148
Afife Zeynep YılmazDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0001-5848-4552
Elif Hilal SaldereDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0003-1045-1131
Fügen YörükDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06230 Ankara, Turkey.ORCID 0000-0001-7487-8439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal resistanceCandida auriscandidemiaintensive care unitmortality predictors

Identifiers

PMID40863504
PMCPMC12387453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.